News blog

Byotrol

  • BY: Andrew Hore |
  • POSTED: 22/11/2011 |

Anti microbial hygiene technology developer Byotrol’s interim revenues were slightly ahead of expectations but it has to do even better in the second half to meet forecasts. 

Revenues were flat at £923,000 in the six months to September 2011. The cash outflow from operations decreased from £1.24m to £1.07m. Net cash was £469,000 at the end of September 2011, but since then £2.46m gross (£2.26m net) has been raised.

Full year revenues are forecast to grow from £1.9m to £3.1m as new contracts with the likes of Rentokil Initial and Marks & Spencer Deli, where sites are being rolled out across the country, start to generate revenues. Once the Rentokil Initial contract gets going it could generate several million pounds a year.

Byotrol has ended its exclusive agreement with Synergy Healthcare, which leaves it free to look for new partners in the healthcare sector.

The overhead base should be relatively fixed so these additional revenues will help to move Byotrol into profit in 2012-13.

At 8.12p a share, Byotrol is valued at £11.7m.

Download the latest AIM Journal from http://www.hubinvest.com/AIMPDFNovember2011_26.pdf

© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds